Published 16 days ago • loading... • Updated 15 days ago

An oncologic drug that is effective against covid can also fight Zika, herpes, or hepatitis C.

Summary by sport.es

Plitidepsin, an antitumor drug that has been used for years in the field of oncology, has the potential to treat also different viruses, such as SARS-CoV-2, MERS, Zika, the respiratory syncitial virus (RSV, bronchiolitis), hepatitis C and herpes, among others. This is demonstrated by a study by IrsiCaixa, a center promoted by La Caixa and the Catalan Health Council, recently published in 'Nature Communications'. This drug could also be effective…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

6 Articles

All

Left

Center

Right

one.com.mt

Oncology service in the comfort of home thanks to the Pink October-Movember campaign

Cancer patients face a number of challenges, not least in the distress of having to visit the hospital even several times in the same week. To this end, the ‘Oncology Outreach Service’ project was launched by the Marigold Foundation and in collaboration with the Sir Anthony Mamo Oncology Hospital to facilitate the lives of these patients. ADVERTISEMENT SCROLL TO CONTINUE The comprehensive programme offers a range of services, which are not n…

15 days ago

Read Full Article

diarioestrategia.cl

One study finds that an antitumor drug is effective against several viruses

A study of IrsiCaixa has demonstrated the potential of an antitumor drug, 'plitidepsin', to treat different viruses, including Sars-Cov2, MERS, Zika, respiratory syncithial virus, hepatitis C virus, and herpes virus.

16 days ago

Read Full Article